chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Enterovirus test negative, Fungal test, General physical health deterioration
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hiatus hernia, Human metapneumovirus test, Human rhinovirus test, Hypoxia, Illness
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Influenza A virus test negative, Influenza B virus test, Influenza virus test negative, Lactic acidosis, Left ventricular failure
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Liver function test increased, Lung infiltration, Lung opacity, Malnutrition, Mycobacterium test negative
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Mycoplasma test negative, Nephrolithiasis, Pleural effusion, Pneumonia bacterial, Pneumothorax
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary hypertension, Pulmonary oedema, Renal failure, Respiratory syncytial virus test negative, Respiratory tract congestion
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Respiratory viral panel, SARS-CoV-2 test positive, Septic shock, Somnolence, Ultrasound Doppler abnormal
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound chest, Ultrasound liver abnormal, Urine output decreased, Viral test negative, X-ray
Clinical narrative: ED to Hosp-Admission  Discharged 8/27/2021 - 9/15/2021 (19 days) Last attending ? Treatment team Acute on chronic diastolic (congestive) heart failure Final Summary for Deceased Patient   BRIEF OVERVIEW Admitting Provider: MD Discharge Provider: MD Primary Care Physician at Discharge: MD    Admission Date: 8/27/2021     Discharge Date: 9/15/2021   Final Diagnosis Principal Problem:   Acute on chronic diastolic (congestive) heart failure  Active Problems:   Paroxysmal A-fib   Pulmonary hypertension, moderate to severe   Chronic obstructive pulmonary disease with acute exacerbation   Pleural effusion on right   End stage COPD   Congestive heart failure, unspecified HF chronicity, unspecified heart failure type   Endocarditis   Lactic acidosis     DETAILS OF HOSPITAL STAY   Date and time of death: September 15, 2021, 12:11 PM   Cause of death: Septic shock from COVID-19 pneumonia Acute respiratory failure from COVID-19 and systolic heart failure   Secondary diagnoses: Severe aortic insufficiency Superimposed bacterial pneumonia Acute renal failure Lactic acidosis Possible endocarditis Atrial fibrillation with rapid ventricular response End-stage COPD Elevated LFTs Coagulopathy from malnutrition and acute illness   Hospital Course Patient is a 72-year-old female with history of COPD, atrial fibrillation on Coumadin, systolic heart failure, recent TMVR presented to the hospital with systolic heart failure.  She is admitted to medical service and seen by the heart failure team.  Echocardiogram showed severe aortic insufficiency and was being considered for valve intervention.  She was treated with IV diuretics however her respiratory status did not improve.  Hospital course was prolonged and she was hospitalized for 18 days.  There is consideration of endocarditis given possible vegetations noted on aortic valve.  CT surgery recommended aggressive antibiotic regimen and stated she was high risk for surgery.  Initially was plan for IV antibiotics through October 4.  She was treated with Lasix infusion, however urine output became marginal.  Patient's x-ray developed progressive infiltrates and on September 14 she was found to have COVID-19 infection.  She was started on steroids and received plasma as well.  Antibiotics were also broadened to cover potential superimposed bacterial pneumonia.  Despite this, her clinical condition deteriorated.  She developed progressive renal failure as well as elevated LFTs and coagulopathy.  She became more somnolent and oxygen requirement escalated.  She became progressively critically ill and was requiring vasopressors, and was maxed on norepinephrine.  Unfortunately, she continued to deteriorate and passed away on September 15.  I passed along my condolences to the patient's son.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anger, Herpes zoster
Clinical narrative: Shingles diagnosis after second shot.  Back of right leg.  Took medication.  Shingles gone for 3 weeks Shingles came back same area of leg on 10/2.  Got prescription immediately
Age: 46.0
Sex: F
Vaccine: FLUC4
Symptoms: Discomfort, Fatigue, Headache, Injection site rash, Injection site swelling
Clinical narrative: OCTOBER 1---5:00 pm: too tired to stay awake, 11:00 splitting headache and body discomfort OCTOBER 2---7:00am woke to terrible headache, 103 degree fever, light sensitivity and body aches, left armpit swelling continued until the size of a tennis ball.  It appeared and felt like it was full of water.  Lymph node was sensitive, very painful and movement of my arm sent stabs of pain into my body. Rash around injection site approx 9 inches from top to bottom began to show in morning.  Increased through out day  and became swollen and hot.  Took more ibuprofen than advised and fever ranged from 98.9 to 102.5 depending on when I had taken ibuprofen.  OCTOBER 3-----Felt a bit better. Still maintained 99 degree fever and headache.  lympnode and rash stayed the same size.  OCTOBER 4----Woke to a pounding stabbing headache and 100 fever.  Two hours after taking ibuprofen headache decreased. Lymphnode swelling had gone down about 80% Rash was no longer swollen though still hot.   Note that all these symptoms I had after taking Covid shot #2.  Tho they were much worse with the Covid shot.  The symptoms are so similar to Covid Vaccine I wondered if they gave me wrong injection.  I cannot get the dr to tell me what brand the vaccine was so I can see if it was the one I was given .  The vial the nurse drew from was purple and white.
Age: 46.0
Sex: F
Vaccine: FLUC4
Symptoms: Injection site warmth, Lymph node pain, Lymphadenopathy, Pain, Photophobia
Clinical narrative: OCTOBER 1---5:00 pm: too tired to stay awake, 11:00 splitting headache and body discomfort OCTOBER 2---7:00am woke to terrible headache, 103 degree fever, light sensitivity and body aches, left armpit swelling continued until the size of a tennis ball.  It appeared and felt like it was full of water.  Lymph node was sensitive, very painful and movement of my arm sent stabs of pain into my body. Rash around injection site approx 9 inches from top to bottom began to show in morning.  Increased through out day  and became swollen and hot.  Took more ibuprofen than advised and fever ranged from 98.9 to 102.5 depending on when I had taken ibuprofen.  OCTOBER 3-----Felt a bit better. Still maintained 99 degree fever and headache.  lympnode and rash stayed the same size.  OCTOBER 4----Woke to a pounding stabbing headache and 100 fever.  Two hours after taking ibuprofen headache decreased. Lymphnode swelling had gone down about 80% Rash was no longer swollen though still hot.   Note that all these symptoms I had after taking Covid shot #2.  Tho they were much worse with the Covid shot.  The symptoms are so similar to Covid Vaccine I wondered if they gave me wrong injection.  I cannot get the dr to tell me what brand the vaccine was so I can see if it was the one I was given .  The vial the nurse drew from was purple and white.
Age: 46.0
Sex: F
Vaccine: FLUC4
Symptoms: Pyrexia, Swelling
Clinical narrative: OCTOBER 1---5:00 pm: too tired to stay awake, 11:00 splitting headache and body discomfort OCTOBER 2---7:00am woke to terrible headache, 103 degree fever, light sensitivity and body aches, left armpit swelling continued until the size of a tennis ball.  It appeared and felt like it was full of water.  Lymph node was sensitive, very painful and movement of my arm sent stabs of pain into my body. Rash around injection site approx 9 inches from top to bottom began to show in morning.  Increased through out day  and became swollen and hot.  Took more ibuprofen than advised and fever ranged from 98.9 to 102.5 depending on when I had taken ibuprofen.  OCTOBER 3-----Felt a bit better. Still maintained 99 degree fever and headache.  lympnode and rash stayed the same size.  OCTOBER 4----Woke to a pounding stabbing headache and 100 fever.  Two hours after taking ibuprofen headache decreased. Lymphnode swelling had gone down about 80% Rash was no longer swollen though still hot.   Note that all these symptoms I had after taking Covid shot #2.  Tho they were much worse with the Covid shot.  The symptoms are so similar to Covid Vaccine I wondered if they gave me wrong injection.  I cannot get the dr to tell me what brand the vaccine was so I can see if it was the one I was given .  The vial the nurse drew from was purple and white.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Aphasia, Condition aggravated, Disease progression, Parkinson's disease, Speech disorder
Clinical narrative: since the vaccination, her symptoms of parkinson's have greatly accelerated.  She was able to communicate at the time of the vaccination.  Now, four months later; she cannot talk and has lost weight and has advanced the disease.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: since the vaccination, her symptoms of parkinson's have greatly accelerated.  She was able to communicate at the time of the vaccination.  Now, four months later; she cannot talk and has lost weight and has advanced the disease.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Tested Positive for Covid
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Chest pain, Cold sweat, Dizziness, Gingival pain
Clinical narrative: Tingling in Arms, Chest Pain, Mouth, Gum & Teeth Pain, Swollen Lymph Nodes, Swollen and raised lump at injection site, Hot and cold Sweats, Dizziness, loss of balance
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Hyperhidrosis, Injection site mass, Injection site swelling, Lymphadenopathy, Oral pain
Clinical narrative: Tingling in Arms, Chest Pain, Mouth, Gum & Teeth Pain, Swollen Lymph Nodes, Swollen and raised lump at injection site, Hot and cold Sweats, Dizziness, loss of balance
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Toothache
Clinical narrative: Tingling in Arms, Chest Pain, Mouth, Gum & Teeth Pain, Swollen Lymph Nodes, Swollen and raised lump at injection site, Hot and cold Sweats, Dizziness, loss of balance
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Acute respiratory failure, Adrenal mass, Agitation, Anxiety
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Biopsy adrenal gland abnormal, C-reactive protein increased, COVID-19, COVID-19 pneumonia
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram head abnormal, Computerised tomogram thorax, Computerised tomogram thorax abnormal, Condition aggravated
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dementia, Dysphonia, Dyspnoea, Dyspnoea exertional
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Endoscopy, Fatigue, General physical health deterioration, Intensive care, Intentional medical device removal by patient
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Laryngeal ventricle prolapse, Lung adenocarcinoma, Lymphadenopathy, Mass, Oxygen saturation decreased
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pleuritic pain, Positron emission tomogram abnormal, Pulmonary mass, Respiratory failure, SARS-CoV-2 test positive
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Spleen disorder, Vocal cord bowing, Weight decreased
Clinical narrative: 66 yo female with PMH of HTN, HLD, DM2, CKD (baseline creatinine 1.0-1.2), dementia (AOx 2-3), recently diagnosed metastatic lung adenocarcinoma (not yet formally seen by onc), hx of smoking (0.5pd x 30 years, quit 2013), COVID+ on 9/21/21 who presents 9/23/2021 with shortness of breath. Transferred to ICU on 9/25 for AHRF with likely in the setting of worsening COVID PNA and anxiety.   From July-Sept, patient reported increasing fatigue, weight loss, and SOB. Patient was diagnosed with metastatic lung adenocarcinoma, following confirmatory biopsy on 9/17.  Furthermore, patient tested positive for COVID on 9/21. Patient is vaccinated with pfizer (4/22/21 and 5/13/21). She was admitted on 9/23 with CRP of 13.2. While on the wards, patient was on 2-6 LPM O2. On 9/25, patient with desaturations and a rapid was called. Patient found to have accessory breathing and continual self-removement of HFNC/ NRB from anxiety. She was admitted to the ICU for escalation of O2 therapy in the setting of respiratory failure and precedex drip for agitation. CRP increased from to 25.9 (9/25). Empiric PE treatment with lovenox was started but CT PA was negative for PE. Despite treatment with remdesivir, decadron, and tocilizumab, patient's condition worsened and eventually required maximum settings on HFNC, NRB, and iNO. Per palliative meeting on 9/28, family would like patient to be intubated if necessary if no family member can be by her side. Their main goal is to get the patient home and they are open to home hospice if the patient can be transported home while alive. Patient is scheduled to be transported via ambulance with HFNC and NRB on 9/30. Grandson, who is vaccinated, is approved to be present throughout the transition from hospital to home hospice.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Nausea, Pain
Clinical narrative: Nauseous, dizziness (within 15 minutes), headache (within 18 hours), chills, body aches, low grade fever, sore arm
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Nauseous, dizziness (within 15 minutes), headache (within 18 hours), chills, body aches, low grade fever, sore arm
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Nausea, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Fever, headache, nausea, vomiting, and joint pain.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Fever, headache, nausea, vomiting, and joint pain.
Age: 32.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abortion spontaneous, COVID-19, Exposure during pregnancy, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID-19 9/1/21 miscarriage 9/7/21
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Covid Clinic scheduled for residents at Home on 10/4/2021. Facility Director of Nursing took Public Health Staff room to room to administer vaccine. Director of Nursing had already completed the needed paper forms prior to clinic. This resident inadvertently received a fourth dose of the pfizer covid 19 vaccine and it was not discovered until entering data into the immunization registry. No adverse effects at this time. Physician notified of the incident.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine error-vaccine was administered past its beyond use date.  The vaccine had been stored in the freezer beyond the time frame recommended by the manufacturer.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Polymenorrhoea
Clinical narrative: Period 2 weeks after last period.  Typically 35-40 day cycles.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Anosmia, COVID-19, Cough, Headache, Oropharyngeal pain
Clinical narrative: Patient contracted COVID after being fully vaccinated Runny Nose, Cough, Loss of Smell, sore throat, headache
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Rhinorrhoea, Streptococcus test
Clinical narrative: Patient contracted COVID after being fully vaccinated Runny Nose, Cough, Loss of Smell, sore throat, headache
Age: 0.17
Sex: M
Vaccine: TDAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Patient was given a Tdap when he was supposed to be given a Dtap.  No adverse effects or reactions.
Age: 47.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: L arm got red 4 inches down from injection site up to L side of neck approximately 5minutes after injection. became slightly warm to the touch, very itchy. took a benadryl 10-15minutes after sx started, immediate relief of sx.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Hypertension
Clinical narrative: Blood pressure  2014/97 within 10 min.   Still is high